DISCLAIMER: PRINTED COPIES ARE FOR REFERENCE ONLY. PLEASE REFER TO THE ELECTRONIC COPY FOR THE LATEST VERSION.
TREATMENT PROTOCOL S-136
RESPIRATORY DISTRESS
Date: 7/1/2025 Page 1 of 1
BLS ALS
• Ensure patent airway
• Reassurance
• Dislodge any airway obstruction. Treat per
Airway Obstruction Protocol (S-121)
• O2 saturation
• O2 and/or ventilate PRN
• Transport in position of comfort
• Carboxyhemoglobin monitor PRN, if available
• May assist patient to self-medicate own
prescribed MDI once only. BH contact
required for additional dose(s)
Toxic inhalation (e.g., CO exposure, smoke,
gas)
• Move patient to safe environment
• 100% O2 via mask
• Consider transport to facility with hyperbaric
chamber for suspected CO poisoning for
unconscious or pregnant patients
Croup-like cough
• Aerosolized saline or water 5 mL via O2-
powered nebulizer/mask, MR PRN
• Monitor/ECG
• Capnography
• IV/IO Ⓐ
• Intubate PRN
• NG/OG PRN
Suspected CHF/cardiac origin
• NTG1 SL
• If systolic BP ≥100 but <150: NTG 0.4 mg SL, MR q3-
5 min Ⓐ
• If systolic BP ≥150: NTG 0.8 mg SL, MR q3-5 min Ⓐ
• CPAP 5-10 cmH2O
Suspected non-cardiac origin2
• Albuterol/Levalbuterol 6 mL via nebulizer, MR Ⓐ
• Ipratropium bromide 2.5 mL 0.02% via nebulizer added to
first dose of albuterol/levalbuterol
• CPAP 5-10 cmH2O
Unable to tolerate CPAP
• Midazolam 0.5-1 mg IM/IN/IV
Severe respiratory distress/failure or inadequate response
to nebulized treatments consider
History of asthma or suspected allergic reaction
• Epinephrine 1:1,000 (1 mg/mL) 0.5 mg IM, MR x2 q5 min Ⓐ
Intubated patients with agitation and potential for airway
compromise
• Midazolam 2-5 mg IM/IN/IV/IO, MR x1 in 5-10 min
Notes:
• For respiratory arrest, immediately start BVM ventilation
• Use caution with CPAP in patients with COPD; start low and titrate pressure
• Epinephrine IM: Use caution if known cardiac history, history of hypertension, SBP >150 mmHg, or age >40
• Fireline paramedics without access to O2 may use MDI
1 NTG is contraindicated in patients who have taken erectile dysfunction medications such as sildenafil (Viagra®), tadalafil (Cialis®), and vardenafil
(Levitra®) within 48 hours; and pulmonary hypertension medications such as sildenafil (Revatio®), and epoprostenol sodium (Flolan®) and (Veletri®) 2 Infection control: If concerned about aerosolized infectious exposure, substitute with MDI, if available

